New combo therapy may fix slow blood flow after heart attack stenting
NCT ID NCT07195812
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding the blood thinner rivaroxaban to standard aspirin and clopidogrel can improve sluggish blood flow in heart attack patients who just had a stent placed. About 60 adults will receive either the triple therapy or standard dual therapy for one month. Researchers will measure blood flow changes and track heart events and bleeding over a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NO-REFLOW PHENOMENON are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which strategy wins for heart attack patients with multiple blocked arteries?
- Could dropping aspirin after a heart attack save hearts?
- Insulin resistance may predict poor blood flow after heart attack stenting in diabetics
- Avatar game teaches heart attack patients how to recover
- Virtual nature walks could soothe heart attack patients in intensive care
- Hand vs. wrist: which route to the heart is safer during a heart attack?